Compare COPR & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | COPR | DRIO |
|---|---|---|
| Founded | N/A | 2011 |
| Country | | United States |
| Employees | 32 | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 54.0M | 52.8M |
| IPO Year | N/A | 2013 |
| Metric | COPR | DRIO |
|---|---|---|
| Price | $2.21 | $7.00 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $35.00 |
| AVG Volume (30 Days) | ★ 34.2K | 18.9K |
| Earning Date | N/A | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1559.02 |
| EPS | N/A | ★ 1.25 |
| Revenue | N/A | ★ $7,394,000.00 |
| Revenue This Year | N/A | $20.27 |
| Revenue Next Year | N/A | $47.58 |
| P/E Ratio | ★ N/A | $5.68 |
| Revenue Growth | N/A | ★ 43.02 |
| 52 Week Low | $2.16 | $0.38 |
| 52 Week High | $4.16 | $17.74 |
| Indicator | COPR | DRIO |
|---|---|---|
| Relative Strength Index (RSI) | 8.29 | 49.14 |
| Support Level | N/A | $6.12 |
| Resistance Level | $3.00 | $9.24 |
| Average True Range (ATR) | 0.31 | 0.70 |
| MACD | -0.07 | 0.06 |
| Stochastic Oscillator | 0.00 | 49.56 |
Idaho Copper Corp is a USA-based company focused on exploring and developing its copper-molybdenum-silver deposit in Idaho, known as the CuMo project. The CuMo project currently consists of several federal unpatented lode mining claims and various patented mining claims. The unpatented lode mining claims and patented claims are situated in an unorganized mining district, in Boise County, Idaho, spanning Sections in Township 7N and 8N, Range 5E and 6E, Boise Meridian.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.